{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T01:11:57Z","timestamp":1784077917881,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003993","name":"Ministry of Agriculture, Forestry and Fisheries of Japan","doi-asserted-by":"publisher","award":["FY2018-2022"],"award-info":[{"award-number":["FY2018-2022"]}],"id":[{"id":"10.13039\/501100003993","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.vaccine.2019.10.098","type":"journal-article","created":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T09:06:18Z","timestamp":1573463178000},"page":"822-829","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Improvement of a recombinant avian avulavirus serotype 10 vectored vaccine by the addition of untranslated regions"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6204-1233","authenticated-orcid":false,"given":"Ryota","family":"Tsunekuni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taichiro","family":"Tanikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Nakaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiko","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.10.098_b0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/viro.1999.9820","article-title":"Genetic characterization of the pathogenic influenza A\/goose\/guangdong\/1\/96 (H5N1) virus: similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong","volume":"261","author":"Xu","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2019.10.098_b0010","unstructured":"World_Organisation_for_Animal_Health. OIE situation report for avian influenza (latest update: 31 August 2018) http:\/\/www.oie.int\/en\/animal-health-in-the-world\/update-on-avian-influenza\/2018\/."},{"key":"10.1016\/j.vaccine.2019.10.098_b0015","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/irv.12289","article-title":"A novel highly pathogenic H5N8 avian influenza virus isolated from a wild duck in China","volume":"8","author":"Fan","year":"2014","journal-title":"Influenza Other Respir Viruses"},{"issue":"5","key":"10.1016\/j.vaccine.2019.10.098_b0020","doi-asserted-by":"crossref","DOI":"10.1128\/genomeA.00706-14","article-title":"Whole-genome sequence of a reassortant H5N6 avian influenza virus isolated from a live poultry market in China, 2013","volume":"2","author":"Qi","year":"2014","journal-title":"Genome Announ"},{"key":"10.1016\/j.vaccine.2019.10.098_b0025","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4142\/jvs.2017.18.S1.269","article-title":"Evolution, global spread, and pathogenicity of highly pathogenic avian influenza H5Nx clade 2.3.4.4","volume":"18","author":"Lee","year":"2017","journal-title":"J Vet Sci"},{"key":"10.1016\/j.vaccine.2019.10.098_b0030","doi-asserted-by":"crossref","first-page":"9484","DOI":"10.1038\/srep09484","article-title":"Reassortant highly pathogenic influenza A H5N2 virus containing gene segments related to Eurasian H5N8 in British Columbia, Canada, 2014","volume":"5","author":"Pasick","year":"2015","journal-title":"Sci Rep."},{"key":"10.1016\/j.vaccine.2019.10.098_b0035","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/0307945031000121077","article-title":"The use of vaccination as an option for the control of avian influenza","volume":"32","author":"Capua","year":"2003","journal-title":"Avian Pathol: J W.V.P.A."},{"key":"10.1016\/j.vaccine.2019.10.098_b0040","first-page":"198","article-title":"Avian influenza vaccination in Egypt: limitations of the current strategy","volume":"3","author":"Peyre","year":"2009","journal-title":"J Mol Genet Med"},{"key":"10.1016\/j.vaccine.2019.10.098_b0045","doi-asserted-by":"crossref","first-page":"267","DOI":"10.20506\/rst.28.1.1860","article-title":"Avian influenza vaccination: the experience in China","volume":"28","author":"Chen","year":"2009","journal-title":"Rev Sci Tech Off Int Epiz"},{"key":"10.1016\/j.vaccine.2019.10.098_b0050","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1017\/S0950268812001628","article-title":"Evaluation of the vaccination efficacy against H5N1 in domestic poultry in the Red River Delta in Vietnam","volume":"141","author":"Desvaux","year":"2013","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2019.10.098_b0055","doi-asserted-by":"crossref","first-page":"633","DOI":"10.20506\/rst.27.3.1823","article-title":"Field trial for assessment of avian influenza vaccination effectiveness in Indonesia","volume":"27","author":"Bouma","year":"2008","journal-title":"Rev Sci Tech"},{"key":"10.1016\/j.vaccine.2019.10.098_b0060","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1637\/10207-041512-Review.1","article-title":"DIVA Vaccination Strategies for Avian Influenza Virus","volume":"56","author":"Suarez","year":"2012","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2019.10.098_b0065","doi-asserted-by":"crossref","first-page":"8257","DOI":"10.1016\/j.vaccine.2011.08.115","article-title":"Recombinant herpesvirus of turkeys as a vector-based vaccine against highly pathogenic H7N1 avian influenza and Marek's disease","volume":"29","author":"Li","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.098_b0070","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.vaccine.2008.11.044","article-title":"Prime-boost vaccination with a fowlpox vector and an inactivated avian influenza vaccine is highly immunogenic in Pekin ducks challenged with Asian H5N1 HPAI","volume":"27","author":"Steensels","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.098_b0075","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1016\/j.vaccine.2009.06.048","article-title":"Live vaccination with an H5-hemagglutinin-expressing infectious laryngotracheitis virus recombinant protects chickens against different highly pathogenic avian influenza viruses of the H5 subtype","volume":"27","author":"Pavlova","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.098_b0080","doi-asserted-by":"crossref","first-page":"e53340","DOI":"10.1371\/journal.pone.0053340","article-title":"Avirulent Marek's disease virus type 1 strain 814 vectored vaccine expressing avian influenza (AI) virus H5 haemagglutinin induced better protection than turkey herpesvirus vectored AI vaccine","volume":"8","author":"Cui","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.10.098_b0085","doi-asserted-by":"crossref","first-page":"11868","DOI":"10.1128\/JVI.75.23.11868-11873.2001","article-title":"Recombinant Newcastle disease virus as a vaccine vector","volume":"75","author":"Nakaya","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.10.098_b0090","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.biologicals.2005.08.003","article-title":"Overview of avian influenza DIVA test strategies","volume":"33","author":"Suarez","year":"2005","journal-title":"Biol: J Int Assoc Biol Stand"},{"key":"10.1016\/j.vaccine.2019.10.098_b0095","doi-asserted-by":"crossref","first-page":"e72530","DOI":"10.1371\/journal.pone.0072530","article-title":"Chimeric newcastle disease virus protects chickens against avian influenza in the presence of maternally derived NDV immunity","volume":"8","author":"Steglich","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.10.098_b0100","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1007\/s00705-018-4016-2","article-title":"Chimeric Newcastle disease virus-vectored vaccine protects chickens against H9N2 avian influenza virus in the presence of pre-existing NDV immunity","volume":"163","author":"Liu","year":"2018","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2019.10.098_b0105","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF01314148","article-title":"Antigenic mapping and functional analysis of the F protein of Newcastle disease virus using monoclonal antibodies","volume":"90","author":"Abenes","year":"1986","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2019.10.098_b0110","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0168-1702(88)90005-6","article-title":"Mapping of three antigenic sites on the haemagglutinin-neuraminidase protein of Newcastle disease virus","volume":"11","author":"Yusoff","year":"1988","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2019.10.098_b0115","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.vetimm.2014.05.001","article-title":"Evaluation of avian paramyxovirus serotypes 2 to 10 as vaccine vectors in chickens previously immunized against Newcastle disease virus","volume":"160","author":"Tsunekuni","year":"2014","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2019.10.098_b0120","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1016\/j.vaccine.2011.12.090","article-title":"Avian paramyxovirus serotypes 2\u20139 (APMV-2-9) vary in the ability to induce protective immunity in chickens against challenge with virulent Newcastle disease virus (APMV-1)","volume":"30","author":"Nayak","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.098_b0125","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1637\/11512-100616-RegR1","article-title":"Recombinant avian paramyxovirus serotypes 2, 6, and 10 as vaccine vectors for highly pathogenic avian influenza in chickens with antibodies against Newcastle disease virus","volume":"61","author":"Tsunekuni","year":"2017","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2019.10.098_b0130","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.virol.2004.11.016","article-title":"Characterization of H5N1 influenza A viruses isolated during the 2003\u20132004 influenza outbreaks in Japan","volume":"332","author":"Mase","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2019.10.098_b0135","first-page":"493","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Hyg"},{"key":"10.1016\/j.vaccine.2019.10.098_b0140","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1432-1033.1997.00741.x","article-title":"Self-cleaving ribozymes of hepatitis delta virus RNA","volume":"247","author":"Been","year":"1997","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.vaccine.2019.10.098_b0145","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/978-1-4939-2694-7_47","article-title":"Protein detection by Simple Western\u2122 analysis","volume":"1312","author":"Harris","year":"2015","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2019.10.098_b0150","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/1348-0421.12369","article-title":"Pathogenicity of H5N8 highly pathogenic avian influenza viruses isolated from a wild bird fecal specimen and a chicken in Japan in 2014","volume":"60","author":"Tanikawa","year":"2016","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2019.10.098_b0155","series-title":"Manual of diagnostic tests and vaccines for terrestrial animals 2013","article-title":"Newcastle disease","author":"Office International des Epizooties","year":"2013"},{"key":"10.1016\/j.vaccine.2019.10.098_b0160","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.vaccine.2019.10.098_b0165","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1016\/j.vaccine.2017.09.008","article-title":"The role of vaccination in risk mitigation and control of Newcastle disease in poultry","volume":"35","author":"Mayers","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.098_b0170","series-title":"Fields virology","first-page":"1449","article-title":"Paramyxoviridae: the viruses and their replication","author":"Lamb","year":"2006"},{"key":"10.1016\/j.vaccine.2019.10.098_b0175","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.1128\/JVI.02349-15","article-title":"Investigating the influence of ribavirin on human respiratory syncytial virus RNA synthesis by using a high-resolution transcriptome sequencing approach","volume":"90","author":"Aljabr","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.10.098_b0180","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.cell.2015.02.029","article-title":"Codon optimality is a major determinant of mRNA stability","volume":"160","author":"Presnyak","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2019.10.098_b0185","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1128\/JVI.02049-09","article-title":"Role of untranslated regions in regulation of gene expression, replication, and pathogenicity of Newcastle disease virus expressing green fluorescent protein","volume":"84","author":"Kim","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.10.098_b0190","doi-asserted-by":"crossref","first-page":"14346","DOI":"10.1128\/JVI.79.22.14346-14354.2005","article-title":"Long untranslated regions of the measles virus M and F genes control virus replication and cytopathogenicity","volume":"79","author":"Takeda","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.10.098_b0195","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.bbrc.2018.12.044","article-title":"Introduction of a conserved sequence into the 5'UTR of additional transcription down-regulation expression of foreign proteins of measles virus minigenome","volume":"508","author":"Wei","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2019.10.098_b0200","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/febs.12115","article-title":"Translational enhancing activity in 5' UTR of peste des petits ruminants virus fusion gene","volume":"280","author":"Chulakasian","year":"2013","journal-title":"FEBS J"},{"key":"10.1016\/j.vaccine.2019.10.098_b0205","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1016\/j.vaccine.2010.02.090","article-title":"Codon-optimization of the hemagglutinin gene from the novel swine origin H1N1 influenza virus has differential effects on CD4(+) T-cell responses and immune effector mechanisms following DNA electroporation in mice","volume":"28","author":"Tenbusch","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.098_b0210","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1128\/JVI.80.4.1959-1964.2006","article-title":"Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization","volume":"80","author":"Gao","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.10.098_b0215","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1128\/JVI.01443-08","article-title":"Optimization of human immunodeficiency virus gag expression by newcastle disease virus vectors for the induction of potent immune responses","volume":"83","author":"Carnero","year":"2009","journal-title":"J Virol."},{"key":"10.1016\/j.vaccine.2019.10.098_b0220","doi-asserted-by":"crossref","first-page":"8197","DOI":"10.1073\/pnas.0602461103","article-title":"Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza","volume":"103","author":"Veits","year":"2006","journal-title":"PNAS"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19315002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19315002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:37:38Z","timestamp":1759401458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19315002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0264410X19315002"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.10.098","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improvement of a recombinant avian avulavirus serotype 10 vectored vaccine by the addition of untranslated regions","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.10.098","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}